Beijing Jiashi Lianbo Medicine Technology

Beijing Jiashi Lianbo Medicine Technology is a specialty pharmaceutical company based in Beijing, China, dedicated to the development of high-end complex injectable formulations. The company leverages its proprietary fat emulsion drug delivery platform to create improved versions of existing medications, focusing on therapeutic areas such as anesthesia, cardiovascular disease, and cerebrovascular health. Its flagship product, a Nimodipine Fat Emulsion Injection (JS-001), has received regulatory approval in China for the treatment of aneurysmal subarachnoid hemorrhage, offering better vascular tolerance compared to traditional ethanol-based formulations. Jiashi Lianbo's pipeline includes several other injectable emulsions in various stages of clinical development, aiming to address unmet needs in acute care and perioperative medicine. The company operates as a high-tech enterprise integrating R&D, clinical evaluation, and technical services.